{"id":342267,"date":"2025-08-20T17:25:54","date_gmt":"2025-08-20T17:25:54","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-axsome-therapeutics\/"},"modified":"2025-08-20T17:25:54","modified_gmt":"2025-08-20T17:25:54","slug":"how-to-buy-axsome-therapeutics","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/","title":{"rendered":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Axsome Therapeutics, Inc. (AXSM) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Axsome Therapeutics, Inc. (AXSM)"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334054,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-342267","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Axsome Therapeutics, Inc. (AXSM) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu AXSM","h1_source":{"label":"H1","type":"text","formatted_value":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Axsome Therapeutics, Inc. (AXSM) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu AXSM"},"description":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Axsome Therapeutics (AXSM) v\u1edbi ph\u00e2n t\u00edch gi\u00e1 hi\u1ec7n t\u1ea1i, d\u1ef1 b\u00e1o 2025-2030 v\u00e0 chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ea7u t\u01b0 t\u1eebng b\u01b0\u1edbc \u0111\u1ec3 th\u00e0nh c\u00f4ng v\u1edbi c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc.","description_source":{"label":"Description","type":"textarea","formatted_value":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Axsome Therapeutics (AXSM) v\u1edbi ph\u00e2n t\u00edch gi\u00e1 hi\u1ec7n t\u1ea1i, d\u1ef1 b\u00e1o 2025-2030 v\u00e0 chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ea7u t\u01b0 t\u1eebng b\u01b0\u1edbc \u0111\u1ec3 th\u00e0nh c\u00f4ng v\u1edbi c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc."},"intro":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111ang vi\u1ebft l\u1ea1i c\u00e1c quy t\u1eafc \u0111i\u1ec1u tr\u1ecb th\u1ea7n kinh h\u1ecdc? Axsome Therapeutics (AXSM) \u0111\u1ea1i di\u1ec7n cho giao \u0111i\u1ec3m th\u00fa v\u1ecb gi\u1eefa \u0111\u1ed5i m\u1edbi y t\u1ebf v\u00e0 c\u01a1 h\u1ed9i t\u00e0i ch\u00ednh. V\u1edbi c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb \u0111\u1ed9t ph\u00e1 cho tr\u1ea7m c\u1ea3m, \u0111au n\u1eeda \u0111\u1ea7u v\u00e0 r\u1ed1i lo\u1ea1n gi\u1ea5c ng\u1ee7, c\u00f4ng ty n\u00e0y mang \u0111\u1ebfn cho nh\u00e0 \u0111\u1ea7u t\u01b0 c\u01a1 h\u1ed9i tham gia v\u00e0o nh\u1eefng ti\u1ebfn b\u1ed9 y h\u1ecdc thay \u0111\u1ed5i cu\u1ed9c s\u1ed1ng \u0111\u1ed3ng th\u1eddi c\u00f3 th\u1ec3 t\u0103ng tr\u01b0\u1edfng v\u1ed1n c\u1ee7a h\u1ecd.","intro_source":{"label":"Intro","type":"text","formatted_value":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111ang vi\u1ebft l\u1ea1i c\u00e1c quy t\u1eafc \u0111i\u1ec1u tr\u1ecb th\u1ea7n kinh h\u1ecdc? Axsome Therapeutics (AXSM) \u0111\u1ea1i di\u1ec7n cho giao \u0111i\u1ec3m th\u00fa v\u1ecb gi\u1eefa \u0111\u1ed5i m\u1edbi y t\u1ebf v\u00e0 c\u01a1 h\u1ed9i t\u00e0i ch\u00ednh. V\u1edbi c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb \u0111\u1ed9t ph\u00e1 cho tr\u1ea7m c\u1ea3m, \u0111au n\u1eeda \u0111\u1ea7u v\u00e0 r\u1ed1i lo\u1ea1n gi\u1ea5c ng\u1ee7, c\u00f4ng ty n\u00e0y mang \u0111\u1ebfn cho nh\u00e0 \u0111\u1ea7u t\u01b0 c\u01a1 h\u1ed9i tham gia v\u00e0o nh\u1eefng ti\u1ebfn b\u1ed9 y h\u1ecdc thay \u0111\u1ed5i cu\u1ed9c s\u1ed1ng \u0111\u1ed3ng th\u1eddi c\u00f3 th\u1ec3 t\u0103ng tr\u01b0\u1edfng v\u1ed1n c\u1ee7a h\u1ecd."},"body_html":"<h2>\ud83d\udcc8 Ph\u00e2n T\u00edch C\u1ed5 Phi\u1ebfu AXSM: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 V\u1ecb Th\u1ebf Th\u1ecb Tr\u01b0\u1eddng<\/h2> <p>T\u00ednh \u0111\u1ebfn ng\u00e0y 20 th\u00e1ng 8 n\u0103m 2025, Axsome Therapeutics (AXSM) giao d\u1ecbch \u1edf m\u1ee9c <strong>111,29 USD<\/strong> tr\u00ean s\u00e0n NASDAQ. M\u1ee9c gi\u00e1 n\u00e0y \u0111\u1ea1i di\u1ec7n cho m\u1ed9t th\u1eddi \u0111i\u1ec3m h\u1ea5p d\u1eabn cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0\u2014c\u1ed5 phi\u1ebfu \u0111ang th\u1ea5p h\u01a1n kho\u1ea3ng 25% so v\u1edbi m\u1ee9c cao 52 tu\u1ea7n l\u00e0 139,13 USD nh\u01b0ng v\u1eabn duy tr\u00ec m\u1ee9c cao h\u01a1n 32% so v\u1edbi m\u1ee9c th\u1ea5p trong n\u0103m l\u00e0 75,56 USD.<\/p> <p><strong>\u0110\u00e1nh d\u1ea5u l\u1ecbch c\u1ee7a b\u1ea1n: Th\u00e1ng 11 n\u0103m 2025 l\u00e0 th\u1eddi \u0111i\u1ec3m quan tr\u1ecdng.<\/strong> \u0110\u00e2y l\u00e0 l\u00fac Axsome d\u1ef1 ki\u1ebfn s\u1ebd c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o thu nh\u1eadp qu\u00fd 3. L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c th\u00f4ng b\u00e1o h\u00e0ng qu\u00fd n\u00e0y th\u01b0\u1eddng t\u1ea1o ra bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3, khi\u1ebfn ng\u00e0y n\u00e0y tr\u1edf n\u00ean thi\u1ebft y\u1ebfu cho c\u1ea3 quy\u1ebft \u0111\u1ecbnh v\u00e0o v\u00e0 ra th\u1ecb tr\u01b0\u1eddng.<\/p> <h3>Ph\u00e2n T\u00edch T\u00e1c \u0110\u1ed9ng B\u00e1o C\u00e1o Thu Nh\u1eadp L\u1ecbch S\u1eed<\/h3> <p>H\u00e3y xem x\u00e9t c\u00e1ch c\u00e1c b\u00e1o c\u00e1o thu nh\u1eadp tr\u01b0\u1edbc \u0111\u00e2y \u0111\u00e3 \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn c\u1ed5 phi\u1ebfu AXSM:<\/p> <table> <thead> <tr><th>Ng\u00e0y<\/th><th>S\u1ef1 ki\u1ec7n<\/th><th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th><th>Thay \u0110\u1ed5i Sau Tin<\/th><\/tr> <\/thead> <tbody> <tr><td>4 Th\u00e1ng 8, 2025<\/td><td>Thu nh\u1eadp Q2<\/td><td>Ph\u1ea1m vi 105-108 USD<\/td><td>+3-5% (v\u01b0\u1ee3t k\u1ef3 v\u1ecdng)<\/td><\/tr> <tr><td>Th\u00e1ng 5, 2025<\/td><td>Thu nh\u1eadp Q1<\/td><td>Ph\u1ea1m vi 98-102 USD<\/td><td>+8-12% (t\u0103ng tr\u01b0\u1edfng doanh thu m\u1ea1nh)<\/td><\/tr> <tr><td>Th\u00e1ng 2, 2025<\/td><td>K\u1ebft qu\u1ea3 h\u00e0ng n\u0103m<\/td><td>Ph\u1ea1m vi 92-95 USD<\/td><td>+15-18% (h\u00e0o h\u1ee9ng v\u1edbi pipeline)<\/td><\/tr> <tr><td>Th\u00e1ng 11, 2024<\/td><td>Ra m\u1eaft s\u1ea3n ph\u1ea9m<\/td><td>Ph\u1ea1m vi 85-88 USD<\/td><td>+6-8% (m\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng)<\/td><\/tr> <tr><td>Th\u00e1ng 8, 2024<\/td><td>Thu nh\u1eadp Q2<\/td><td>Ph\u1ea1m vi 80-83 USD<\/td><td>-4-6% (ch\u1ec9 h\u01a1i h\u1ee5t m\u1ee5c ti\u00eau)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Nh\u1eadn \u0111\u1ecbnh xu h\u01b0\u1edbng<\/strong>: C\u00e1c b\u1ea5t ng\u1edd t\u00edch c\u1ef1c v\u1ec1 thu nh\u1eadp th\u01b0\u1eddng \u0111\u1ea9y AXSM t\u0103ng 5-15%, trong khi nh\u1eefng sai s\u00f3t nh\u1ecf c\u0169ng g\u00e2y ra s\u1ee5t gi\u1ea3m t\u1ea1m th\u1eddi 3-8%. C\u1ed5 phi\u1ebfu li\u00ean t\u1ee5c h\u1ed3i ph\u1ee5c nh\u1edd n\u1ec1n t\u1ea3ng v\u1eefng ch\u1eafc v\u00e0 ti\u1ec1m n\u0103ng pipeline.<\/p> <h3>H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng (Th\u00e1ng 3 - Th\u00e1ng 8, 2025)<\/h3> <p>C\u1ed5 phi\u1ebfu AXSM \u0111\u00e3 th\u1ec3 hi\u1ec7n s\u1ef1 ki\u00ean c\u01b0\u1eddng v\u00e0 t\u0103ng tr\u01b0\u1edfng \u0111\u00e1ng ch\u00fa \u00fd trong giai \u0111o\u1ea1n n\u00e0y:<\/p> <ul> <li><strong>Th\u00e1ng 3, 2025<\/strong>: Ph\u1ea1m vi 95-100 USD (h\u1eadu h\u1ee3p nh\u1ea5t Q4)<\/li> <li><strong>Th\u00e1ng 4, 2025<\/strong>: 102-108 USD (mong \u0111\u1ee3i ph\u00ea duy\u1ec7t SYMBRAVO)<\/li> <li><strong>Th\u00e1ng 5, 2025<\/strong>: 110-115 USD (v\u01b0\u1ee3t thu nh\u1eadp Q1 + t\u0103ng tr\u01b0\u1edfng doanh thu 62%)<\/li> <li><strong>Th\u00e1ng 6, 2025<\/strong>: 118-125 USD (th\u00e0nh c\u00f4ng ra m\u1eaft th\u01b0\u01a1ng m\u1ea1i SYMBRAVO)<\/li> <li><strong>Th\u00e1ng 7, 2025<\/strong>: 120-128 USD (s\u1ef1 ki\u1ec7n rung chu\u00f4ng NASDAQ + ng\u00e0y R&D)<\/li> <li><strong>Th\u00e1ng 8, 2025<\/strong>: 105-112 USD (ch\u1ed1t l\u1eddi sau Q2 + bi\u1ebfn \u0111\u1ed9ng th\u1ecb tr\u01b0\u1eddng)<\/li> <\/ul> <p><strong>T\u1ea1i sao xu h\u01b0\u1edbng t\u0103ng chung?<\/strong><\/p> <ul> <li>T\u0103ng tr\u01b0\u1edfng doanh thu k\u1ef7 l\u1ee5c: 62% YoY trong Q1, 72% YoY trong Q2<\/li> <li>Ra m\u1eaft th\u00e0nh c\u00f4ng thu\u1ed1c \u0111i\u1ec1u tr\u1ecb \u0111au n\u1eeda \u0111\u1ea7u SYMBRAVO<\/li> <li>Nhi\u1ec1u ti\u1ebfn tri\u1ec3n trong c\u00e1c th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n 3<\/li> <li>M\u1edf r\u1ed9ng ti\u1ebfp c\u1eadn th\u1ecb tr\u01b0\u1eddng cho t\u1ea5t c\u1ea3 s\u1ea3n ph\u1ea9m<\/li> <\/ul> [cta_green text=\"B\u1eaft \u0111\u1ea7u giao d\u1ecbch\"]<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2> <p>D\u1ef1a tr\u00ean s\u1ef1 \u0111\u1ed3ng thu\u1eadn c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch hi\u1ec7n t\u1ea1i v\u00e0 c\u00e1c ph\u00e1t tri\u1ec3n trong pipeline, \u0111\u00e2y l\u00e0 nh\u1eefng g\u00ec b\u1ea1n c\u00f3 th\u1ec3 mong \u0111\u1ee3i:<\/p> <ul> <li><strong>M\u1ee5c ti\u00eau cu\u1ed1i n\u0103m 2025<\/strong>: Ph\u1ea1m vi 140-160 USD (t\u0103ng 25-40% so v\u1edbi m\u1ee9c hi\u1ec7n t\u1ea1i)<br> C\u00e1c nh\u00e0 ph\u00e2n t\u00edch duy tr\u00ec \u0111\u00e1nh gi\u00e1 \"Mua M\u1ea1nh\" v\u1edbi m\u1ee5c ti\u00eau gi\u00e1 trung b\u00ecnh kho\u1ea3ng 176-178 USD, m\u1eb7c d\u00f9 c\u00e1c \u01b0\u1edbc t\u00ednh th\u1eadn tr\u1ecdng h\u01a1n cho r\u1eb1ng 140-150 USD l\u00e0 kh\u1ea3 thi trong \u0111i\u1ec1u ki\u1ec7n th\u1ecb tr\u01b0\u1eddng hi\u1ec7n t\u1ea1i.<\/li> <li><strong>D\u1ef1 b\u00e1o 2026<\/strong>: 180-220 USD<br> D\u1ef1 b\u00e1o n\u00e0y gi\u1ea3 \u0111\u1ecbnh c\u00e1c ph\u00ea duy\u1ec7t NDA th\u00e0nh c\u00f4ng cho AXS-05 trong \u0111i\u1ec1u tr\u1ecb k\u00edch \u0111\u1ed9ng Alzheimer v\u00e0 AXS-12 trong ch\u1ee9ng ng\u1ee7 r\u0169, c\u00f9ng v\u1edbi t\u0103ng tr\u01b0\u1edfng doanh thu ti\u1ebfp t\u1ee5c t\u1eeb c\u00e1c s\u1ea3n ph\u1ea9m hi\u1ec7n c\u00f3.<\/li> <li><strong>Tri\u1ec3n v\u1ecdng 2028<\/strong>: 250-350 USD<br> \u0110\u1ebfn n\u0103m 2028, d\u1ef1 ki\u1ebfn s\u1ebd c\u00f3 nhi\u1ec1u s\u1ea3n ph\u1ea9m m\u1edbi ra m\u1eaft v\u00e0 kh\u1ea3 n\u0103ng m\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng qu\u1ed1c t\u1ebf, th\u00fac \u0111\u1ea9y \u0111a d\u1ea1ng h\u00f3a doanh thu \u0111\u00e1ng k\u1ec3.<\/li> <li><strong>T\u1ea7m nh\u00ecn d\u00e0i h\u1ea1n 2030<\/strong>: 400-600 USD<br> N\u1ebfu Axsome th\u1ef1c hi\u1ec7n th\u00e0nh c\u00f4ng chi\u1ebfn l\u01b0\u1ee3c pipeline v\u00e0 chi\u1ebfm \u0111\u01b0\u1ee3c ngay c\u1ea3 m\u1ed9t ph\u1ea7n nh\u1ecf trong th\u1ecb tr\u01b0\u1eddng h\u01a1n 150 tri\u1ec7u b\u1ec7nh nh\u00e2n m\u00e0 h\u1ecd nh\u1eafm t\u1edbi, c\u1ed5 phi\u1ebfu c\u00f3 th\u1ec3 mang l\u1ea1i l\u1ee3i nhu\u1eadn d\u00e0i h\u1ea1n xu\u1ea5t s\u1eafc.<\/li> <\/ul> <p><strong>K\u1ebft lu\u1eadn<\/strong>: MUA M\u1ea0NH cho nh\u00e0 \u0111\u1ea7u t\u01b0 d\u00e0i h\u1ea1n. C\u00e1c nh\u00e0 giao d\u1ecbch ng\u1eafn h\u1ea1n n\u00ean ch\u1edd \u0111\u1ee3i kh\u1ea3 n\u0103ng gi\u1ea3m gi\u00e1 sau b\u00e1o c\u00e1o thu nh\u1eadp v\u00e0o th\u00e1ng 11.<\/p> <h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2> <h3>R\u1ee7i Ro C\u1ea7n Xem X\u00e9t<\/h3> <ul> <li><strong>Th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/strong>: D\u00f9 hi\u1ec7n t\u1ea1i th\u00e0nh c\u00f4ng, b\u1ea5t k\u1ef3 th\u1ea5t b\u1ea1i n\u00e0o trong th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n 3 c\u0169ng c\u00f3 th\u1ec3 khi\u1ebfn c\u1ed5 phi\u1ebfu gi\u1ea3m 30-50% ngay l\u1eadp t\u1ee9c. Ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ea5t bi\u1ebfn \u0111\u1ed9ng quanh k\u1ebft qu\u1ea3 l\u00e2m s\u00e0ng.<\/li> <li><strong>R\u00e0o c\u1ea3n quy \u0111\u1ecbnh FDA<\/strong>: Ngay c\u1ea3 khi th\u1eed nghi\u1ec7m th\u00e0nh c\u00f4ng, vi\u1ec7c FDA t\u1eeb ch\u1ed1i ho\u1eb7c tr\u00ec ho\u00e3n c\u00f3 th\u1ec3 l\u00e0m gi\u00e1 c\u1ed5 phi\u1ebfu s\u1ee5t gi\u1ea3m nghi\u00eam tr\u1ecdng. Vi\u1ec7c c\u00e1c quan ch\u1ee9c FDA ch\u1ee7 ch\u1ed1t g\u1ea7n \u0111\u00e2y r\u1eddi \u0111i l\u00e0m t\u0103ng s\u1ef1 kh\u00f4ng ch\u1eafc ch\u1eafn (<a href=\"https:\/\/www.pharmavoice.com\/news\/biotech-market-ipos-manda-stocks-pharma\/745288\/\">PharmaVoice<\/a>).<\/li> <li><strong>C\u1ea1nh tranh gia t\u0103ng<\/strong>: C\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn h\u01a1n \u0111ang ph\u00e1t tri\u1ec3n c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb th\u1ea7n kinh h\u1ecdc c\u1ea1nh tranh c\u00f3 th\u1ec3 l\u00e0m gi\u1ea3m th\u1ecb ph\u1ea7n.<\/li> <li><strong>Kh\u1ea3 n\u0103ng t\u00e0i ch\u00ednh b\u1ec1n v\u1eefng<\/strong>: M\u1eb7c d\u00f9 doanh thu t\u0103ng \u1ea5n t\u01b0\u1ee3ng, c\u00f4ng ty v\u1eabn ho\u1ea1t \u0111\u1ed9ng thua l\u1ed7 (-246,9 tri\u1ec7u USD TTM). Thua l\u1ed7 ti\u1ebfp t\u1ee5c \u0111\u00f2i h\u1ecfi t\u00e0i tr\u1ee3 th\u00eam c\u00f3 th\u1ec3 l\u00e0m pha lo\u00e3ng gi\u00e1 tr\u1ecb c\u1ed5 \u0111\u00f4ng.<\/li> <\/ul> <h3>T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c Cho 2025-2026<\/h3> <ul> <li><strong>T\u0103ng tr\u01b0\u1edfng doanh thu b\u00f9ng n\u1ed5<\/strong>: T\u0103ng tr\u01b0\u1edfng 72% theo n\u0103m trong Q2 2025 cho th\u1ea5y th\u1ef1c thi th\u01b0\u01a1ng m\u1ea1i m\u1ea1nh m\u1ebd (<a href=\"https:\/\/www.biospace.com\/press-releases\/axsome-therapeutics-reports-second-quarter-2025-financial-results-and-provides-business-update\">BioSpace<\/a>).<\/li> <li><strong>\u0110\u00e0 ph\u00e1t tri\u1ec3n pipeline<\/strong>: B\u1ed1n th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n 3 b\u1ed5 sung b\u1eaft \u0111\u1ea7u trong Q4 2025 tr\u00ean c\u00e1c ch\u1ec9 \u0111\u1ecbnh l\u1edbn bao g\u1ed3m cai thu\u1ed1c l\u00e1 v\u00e0 ADHD tr\u1ebb em.<\/li> <li><strong>M\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng<\/strong>: Vi\u1ec7c ra m\u1eaft th\u01b0\u01a1ng m\u1ea1i SYMBRAVO v\u00e0o th\u00e1ng 6 n\u0103m 2025 b\u1ed5 sung d\u00f2ng doanh thu m\u1edbi b\u00ean c\u1ea1nh th\u00e0nh c\u00f4ng c\u1ee7a AUVELITY.<\/li> <li><strong>Xu h\u01b0\u1edbng ng\u00e0nh<\/strong>: C\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb th\u1ea7n kinh h\u1ecdc l\u00e0 m\u1ed9t trong nh\u1eefng l\u0129nh v\u1ef1c d\u01b0\u1ee3c ph\u1ea9m ph\u00e1t tri\u1ec3n nhanh nh\u1ea5t, v\u1edbi s\u1ef1 gia t\u0103ng b\u1ea3o hi\u1ec3m v\u00e0 nhu c\u1ea7u b\u1ec7nh nh\u00e2n.<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2> <p><strong>\u0110i\u1ec3m v\u00e0o chi\u1ebfn l\u01b0\u1ee3c<\/strong>:<\/p> <ol> <li>S\u1eed d\u1ee5ng ph\u01b0\u01a1ng ph\u00e1p trung b\u00ecnh gi\u00e1 theo \u0111\u00f4 la\u2014\u0111\u1ea7u t\u01b0 s\u1ed1 ti\u1ec1n c\u1ed1 \u0111\u1ecbnh h\u00e0ng tu\u1ea7n thay v\u00ec c\u1ed1 g\u1eafng b\u1eaft th\u1eddi \u0111i\u1ec3m th\u1ecb tr\u01b0\u1eddng<\/li> <li>\u0110\u1eb7t l\u1ec7nh mua \u1edf m\u1ee9c 105-108 USD \u0111\u1ec3 c\u00f3 gi\u00e1 v\u00e0o t\u1ed1t h\u01a1n<\/li> <li>Ph\u00e2n b\u1ed5 kh\u00f4ng qu\u00e1 5-10% danh m\u1ee5c cho c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc c\u00f3 bi\u1ebfn \u0111\u1ed9ng cao<\/li> <\/ol> <p><strong>Qu\u1ea3n l\u00fd r\u1ee7i ro thi\u1ebft y\u1ebfu<\/strong>:<\/p> <ul> <li>\u0110\u1eb7t l\u1ec7nh d\u1eebng l\u1ed7 \u1edf m\u1ee9c 15-20% d\u01b0\u1edbi \u0111i\u1ec3m v\u00e0o<\/li> <li>Ch\u1ed1t l\u1eddi m\u1ed9t ph\u1ea7n khi l\u1ee3i nhu\u1eadn \u0111\u1ea1t 25-30% \u0111\u1ec3 b\u1ea3o v\u1ec7 l\u1ee3i nhu\u1eadn<\/li> <li>Theo d\u00f5i l\u1ecbch FDA cho c\u00e1c ng\u00e0y quy\u1ebft \u0111\u1ecbnh s\u1eafp t\u1edbi<\/li> <\/ul> <p><strong>Ch\u00e2m ng\u00f4n h\u00e0i h\u01b0\u1edbc cho nh\u00e0 giao d\u1ecbch<\/strong>: \"Giao d\u1ecbch c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 v\u1edbi m\u1ed9t nh\u00e0 khoa h\u1ecdc t\u00e0i ba\u2014\u0111\u1ed9t ph\u00e1 h\u1ed3i h\u1ed9p pha l\u1eabn nh\u1eefng v\u1ee5 n\u1ed5 ph\u00f2ng th\u00ed nghi\u1ec7m th\u1ec9nh tho\u1ea3ng. Lu\u00f4n \u0111eo k\u00ednh b\u1ea3o h\u1ed9 an to\u00e0n!\"<\/p> <h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Axsome Therapeutics, Inc. (AXSM) - T\u1eebng B\u01b0\u1edbc<\/h2> <table> <thead> <tr><th>B\u01b0\u1edbc<\/th><th>H\u00e0nh \u0110\u1ed9ng<\/th><th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch c\u1ed5 phi\u1ebfu<\/td><td>\u0110\u1ea3m b\u1ea3o n\u1ec1n t\u1ea3ng c\u00f3 truy c\u1eadp NASDAQ v\u00e0 cho ph\u00e9p mua c\u1ed5 phi\u1ebfu l\u1ebb<\/td><\/tr> <tr><td>2<\/td><td>M\u1edf v\u00e0 n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n<\/td><td>B\u1eaft \u0111\u1ea7u v\u1edbi 50-100 USD \u0111\u1ec3 l\u00e0m quen v\u1edbi c\u01a1 ch\u1ebf n\u1ec1n t\u1ea3ng<\/td><\/tr> <tr><td>3<\/td><td>Nghi\u00ean c\u1ee9u c\u00e1c y\u1ebfu t\u1ed1 c\u01a1 b\u1ea3n c\u1ee7a AXSM<\/td><td>Xem x\u00e9t t\u0103ng tr\u01b0\u1edfng doanh thu, tr\u1ea1ng th\u00e1i pipeline v\u00e0 \u0111\u00e1nh gi\u00e1 c\u1ee7a nh\u00e0 ph\u00e2n t\u00edch<\/td><\/tr> <tr><td>4<\/td><td>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1<\/td><td>Nh\u1eadn th\u00f4ng b\u00e1o t\u1ea1i c\u00e1c m\u1ee9c h\u1ed7 tr\u1ee3 ch\u00ednh (105 USD, 100 USD, 95 USD)<\/td><\/tr> <tr><td>5<\/td><td>Th\u1ef1c hi\u1ec7n l\u1ec7nh gi\u1edbi h\u1ea1n<\/td><td>Mua \u1edf gi\u00e1 m\u1ee5c ti\u00eau thay v\u00ec gi\u00e1 th\u1ecb tr\u01b0\u1eddng<\/td><\/tr> <tr><td>6<\/td><td>Theo d\u00f5i v\u1ecb th\u1ebf th\u01b0\u1eddng xuy\u00ean<\/td><td>Theo d\u00f5i ng\u00e0y c\u00f4ng b\u1ed1 thu nh\u1eadp v\u00e0 c\u00e1c m\u1ed1c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/td><\/tr> <tr><td>7<\/td><td>\u00c1p d\u1ee5ng qu\u1ea3n l\u00fd r\u1ee7i ro<\/td><td>\u0110\u1eb7t m\u1ee9c d\u1eebng l\u1ed7 v\u00e0 ch\u1ed1t l\u1eddi ngay l\u1eadp t\u1ee9c<\/td><\/tr> <tr><td>8<\/td><td>Xem x\u00e9t b\u00e1o c\u00e1o h\u00e0ng qu\u00fd<\/td><td>C\u1eadp nh\u1eadt v\u1ec1 t\u0103ng tr\u01b0\u1edfng doanh thu v\u00e0 ti\u1ebfn tri\u1ec3n pipeline<\/td><\/tr> <tr><td>9<\/td><td>Xem x\u00e9t t\u00e1i \u0111\u1ea7u t\u01b0 c\u1ed5 t\u1ee9c<\/td><td>N\u1ebfu c\u00f3, t\u1ef1 \u0111\u1ed9ng t\u00e1i \u0111\u1ea7u t\u01b0 l\u1ee3i nhu\u1eadn<\/td><\/tr> <tr><td>10<\/td><td>\u0110i\u1ec1u ch\u1ec9nh c\u00e2n b\u1eb1ng \u0111\u1ecbnh k\u1ef3<\/td><td>\u0110i\u1ec1u ch\u1ec9nh k\u00edch th\u01b0\u1edbc v\u1ecb th\u1ebf khi gi\u00e1 tr\u1ecb danh m\u1ee5c thay \u0111\u1ed5i<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 AXSM M\u1edbi<\/h2> <p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi mu\u1ed1n b\u1eaft \u0111\u1ea7u v\u1edbi Axsome Therapeutics, Pocket Option cung c\u1ea5p kh\u1ea3 n\u0103ng ti\u1ebfp c\u1eadn xu\u1ea5t s\u1eafc:<\/p> <ul> <li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u ch\u1ec9 5 USD<\/strong>\u2014th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi r\u1ee7i ro t\u1ed1i thi\u1ec3u tr\u01b0\u1edbc khi cam k\u1ebft s\u1ed1 ti\u1ec1n l\u1edbn h\u01a1n<\/li> <li><strong>X\u00e1c minh KYC trong 1 ph\u00fat<\/strong>\u2014b\u1eaft \u0111\u1ea7u giao d\u1ecbch nhanh ch\u00f3ng v\u1edbi b\u1ea5t k\u1ef3 gi\u1ea5y t\u1edd t\u00f9y th\u00e2n ch\u00ednh ph\u1ee7 n\u00e0o<\/li> <li><strong>H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong>\u2014linh ho\u1ea1t v\u1edbi ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed v\u00e0 c\u00e1c ph\u01b0\u01a1ng th\u1ee9c truy\u1ec1n th\u1ed1ng<\/li> <li><strong>Truy c\u1eadp c\u1ed5 phi\u1ebfu l\u1ebb<\/strong>\u2014mua ph\u1ea7n nh\u1ecf c\u1ee7a AXSM ngay c\u1ea3 v\u1edbi t\u00e0i kho\u1ea3n nh\u1ecf<\/li> <li><strong>D\u1eef li\u1ec7u th\u1ecb tr\u01b0\u1eddng th\u1eddi gian th\u1ef1c<\/strong>\u2014theo d\u00f5i bi\u1ebfn \u0111\u1ed9ng gi\u00e1 AXSM v\u00e0 \u0111\u1eb7t c\u1ea3nh b\u00e1o ngay l\u1eadp t\u1ee9c<\/li> <\/ul> <p>Giao di\u1ec7n th\u00e2n thi\u1ec7n v\u1edbi ng\u01b0\u1eddi d\u00f9ng c\u1ee7a n\u1ec1n t\u1ea3ng l\u00e0m cho n\u00f3 l\u00fd t\u01b0\u1edfng cho ng\u01b0\u1eddi m\u1edbi mu\u1ed1n tham gia \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc m\u00e0 kh\u00f4ng ph\u1ea3i \u0111\u1ed1i m\u1eb7t v\u1edbi s\u1ef1 ph\u1ee9c t\u1ea1p c\u1ee7a c\u00e1c t\u00e0i kho\u1ea3n m\u00f4i gi\u1edbi truy\u1ec1n th\u1ed1ng.<\/p> <h2>\ud83c\udf0d Axsome Therapeutics N\u0103m 2025: Nh\u00e0 L\u00e3nh \u0110\u1ea1o \u0110\u1ed5i M\u1edbi Th\u1ea7n Kinh H\u1ecdc<\/h2> <p>Axsome Therapeutics \u0111\u1ee9ng \u1edf v\u1ecb tr\u00ed ti\u00ean phong trong \u0111\u1ed5i m\u1edbi \u0111i\u1ec1u tr\u1ecb h\u1ec7 th\u1ea7n kinh trung \u01b0\u01a1ng. C\u00f4ng ty hi\u1ec7n \u0111ang ti\u1ebfp th\u1ecb hai s\u1ea3n ph\u1ea9m th\u00e0nh c\u00f4ng\u2014AUVELITY cho tr\u1ea7m c\u1ea3m v\u00e0 SUNOSI cho r\u1ed1i lo\u1ea1n gi\u1ea5c ng\u1ee7\u2014v\u1edbi SYMBRAVO v\u1eeba \u0111\u01b0\u1ee3c ra m\u1eaft cho \u0111i\u1ec1u tr\u1ecb \u0111au n\u1eeda \u0111\u1ea7u c\u1ea5p t\u00ednh.<\/p> <p>Pipeline c\u1ee7a c\u00f4ng ty l\u00e0 m\u1ed9t trong nh\u1eefng m\u1ea1nh m\u1ebd nh\u1ea5t trong l\u0129nh v\u1ef1c th\u1ea7n kinh h\u1ecdc, v\u1edbi c\u00e1c NDA \u0111\u00e3 n\u1ed9p cho b\u1ec7nh \u0111au c\u01a1 x\u01a1 h\u00f3a (AXS-14) v\u00e0 k\u1ebf ho\u1ea1ch n\u1ed9p cho k\u00edch \u0111\u1ed9ng Alzheimer (AXS-05) v\u00e0 ch\u1ee9ng ng\u1ee7 r\u0169 (AXS-12). Chi\u1ebfn l\u01b0\u1ee3c R&D c\u1ee7a h\u1ecd nh\u1eafm \u0111\u1ebfn c\u00e1c b\u1ec7nh \u1ea3nh h\u01b0\u1edfng h\u01a1n 150 tri\u1ec7u b\u1ec7nh nh\u00e2n ch\u1ec9 ri\u00eang t\u1ea1i M\u1ef9, \u0111\u1ea1i di\u1ec7n cho ti\u1ec1m n\u0103ng th\u1ecb tr\u01b0\u1eddng kh\u1ed5ng l\u1ed3.<\/p> <p><strong>S\u1ef1 ki\u1ec7n th\u00fa v\u1ecb n\u0103m 2025<\/strong>: Axsome \u0111\u00e3 g\u00e2y ch\u00fa \u00fd khi rung chu\u00f4ng khai m\u1ea1c NASDAQ v\u00e0o ng\u00e0y 21 th\u00e1ng 7\u2014nh\u01b0ng v\u1edbi m\u1ed9t \u0111i\u1ec3m \u0111\u1eb7c bi\u1ec7t. H\u1ecd s\u1eed d\u1ee5ng c\u00f4ng ngh\u1ec7 \u0111\u1ecdc s\u00f3ng n\u00e3o cho ph\u00e9p CEO Herriot Tabuteau k\u00edch ho\u1ea1t chu\u00f4ng ch\u1ec9 b\u1eb1ng suy ngh\u0129 t\u1eadp trung, th\u1ec3 hi\u1ec7n cam k\u1ebft \u0111\u1ed5i m\u1edbi th\u1ea7n kinh h\u1ecdc v\u01b0\u1ee3t ra ngo\u00e0i d\u01b0\u1ee3c ph\u1ea9m.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Ph\u00e2n T\u00edch C\u1ed5 Phi\u1ebfu AXSM: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 V\u1ecb Th\u1ebf Th\u1ecb Tr\u01b0\u1eddng<\/h2>\n<p>T\u00ednh \u0111\u1ebfn ng\u00e0y 20 th\u00e1ng 8 n\u0103m 2025, Axsome Therapeutics (AXSM) giao d\u1ecbch \u1edf m\u1ee9c <strong>111,29 USD<\/strong> tr\u00ean s\u00e0n NASDAQ. M\u1ee9c gi\u00e1 n\u00e0y \u0111\u1ea1i di\u1ec7n cho m\u1ed9t th\u1eddi \u0111i\u1ec3m h\u1ea5p d\u1eabn cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0\u2014c\u1ed5 phi\u1ebfu \u0111ang th\u1ea5p h\u01a1n kho\u1ea3ng 25% so v\u1edbi m\u1ee9c cao 52 tu\u1ea7n l\u00e0 139,13 USD nh\u01b0ng v\u1eabn duy tr\u00ec m\u1ee9c cao h\u01a1n 32% so v\u1edbi m\u1ee9c th\u1ea5p trong n\u0103m l\u00e0 75,56 USD.<\/p>\n<p><strong>\u0110\u00e1nh d\u1ea5u l\u1ecbch c\u1ee7a b\u1ea1n: Th\u00e1ng 11 n\u0103m 2025 l\u00e0 th\u1eddi \u0111i\u1ec3m quan tr\u1ecdng.<\/strong> \u0110\u00e2y l\u00e0 l\u00fac Axsome d\u1ef1 ki\u1ebfn s\u1ebd c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o thu nh\u1eadp qu\u00fd 3. L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c th\u00f4ng b\u00e1o h\u00e0ng qu\u00fd n\u00e0y th\u01b0\u1eddng t\u1ea1o ra bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3, khi\u1ebfn ng\u00e0y n\u00e0y tr\u1edf n\u00ean thi\u1ebft y\u1ebfu cho c\u1ea3 quy\u1ebft \u0111\u1ecbnh v\u00e0o v\u00e0 ra th\u1ecb tr\u01b0\u1eddng.<\/p>\n<h3>Ph\u00e2n T\u00edch T\u00e1c \u0110\u1ed9ng B\u00e1o C\u00e1o Thu Nh\u1eadp L\u1ecbch S\u1eed<\/h3>\n<p>H\u00e3y xem x\u00e9t c\u00e1ch c\u00e1c b\u00e1o c\u00e1o thu nh\u1eadp tr\u01b0\u1edbc \u0111\u00e2y \u0111\u00e3 \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn c\u1ed5 phi\u1ebfu AXSM:<\/p>\n<table>\n<thead>\n<tr>\n<th>Ng\u00e0y<\/th>\n<th>S\u1ef1 ki\u1ec7n<\/th>\n<th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th>\n<th>Thay \u0110\u1ed5i Sau Tin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>4 Th\u00e1ng 8, 2025<\/td>\n<td>Thu nh\u1eadp Q2<\/td>\n<td>Ph\u1ea1m vi 105-108 USD<\/td>\n<td>+3-5% (v\u01b0\u1ee3t k\u1ef3 v\u1ecdng)<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 5, 2025<\/td>\n<td>Thu nh\u1eadp Q1<\/td>\n<td>Ph\u1ea1m vi 98-102 USD<\/td>\n<td>+8-12% (t\u0103ng tr\u01b0\u1edfng doanh thu m\u1ea1nh)<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 2, 2025<\/td>\n<td>K\u1ebft qu\u1ea3 h\u00e0ng n\u0103m<\/td>\n<td>Ph\u1ea1m vi 92-95 USD<\/td>\n<td>+15-18% (h\u00e0o h\u1ee9ng v\u1edbi pipeline)<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 11, 2024<\/td>\n<td>Ra m\u1eaft s\u1ea3n ph\u1ea9m<\/td>\n<td>Ph\u1ea1m vi 85-88 USD<\/td>\n<td>+6-8% (m\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng)<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 8, 2024<\/td>\n<td>Thu nh\u1eadp Q2<\/td>\n<td>Ph\u1ea1m vi 80-83 USD<\/td>\n<td>-4-6% (ch\u1ec9 h\u01a1i h\u1ee5t m\u1ee5c ti\u00eau)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Nh\u1eadn \u0111\u1ecbnh xu h\u01b0\u1edbng<\/strong>: C\u00e1c b\u1ea5t ng\u1edd t\u00edch c\u1ef1c v\u1ec1 thu nh\u1eadp th\u01b0\u1eddng \u0111\u1ea9y AXSM t\u0103ng 5-15%, trong khi nh\u1eefng sai s\u00f3t nh\u1ecf c\u0169ng g\u00e2y ra s\u1ee5t gi\u1ea3m t\u1ea1m th\u1eddi 3-8%. C\u1ed5 phi\u1ebfu li\u00ean t\u1ee5c h\u1ed3i ph\u1ee5c nh\u1edd n\u1ec1n t\u1ea3ng v\u1eefng ch\u1eafc v\u00e0 ti\u1ec1m n\u0103ng pipeline.<\/p>\n<h3>H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng (Th\u00e1ng 3 &#8211; Th\u00e1ng 8, 2025)<\/h3>\n<p>C\u1ed5 phi\u1ebfu AXSM \u0111\u00e3 th\u1ec3 hi\u1ec7n s\u1ef1 ki\u00ean c\u01b0\u1eddng v\u00e0 t\u0103ng tr\u01b0\u1edfng \u0111\u00e1ng ch\u00fa \u00fd trong giai \u0111o\u1ea1n n\u00e0y:<\/p>\n<ul>\n<li><strong>Th\u00e1ng 3, 2025<\/strong>: Ph\u1ea1m vi 95-100 USD (h\u1eadu h\u1ee3p nh\u1ea5t Q4)<\/li>\n<li><strong>Th\u00e1ng 4, 2025<\/strong>: 102-108 USD (mong \u0111\u1ee3i ph\u00ea duy\u1ec7t SYMBRAVO)<\/li>\n<li><strong>Th\u00e1ng 5, 2025<\/strong>: 110-115 USD (v\u01b0\u1ee3t thu nh\u1eadp Q1 + t\u0103ng tr\u01b0\u1edfng doanh thu 62%)<\/li>\n<li><strong>Th\u00e1ng 6, 2025<\/strong>: 118-125 USD (th\u00e0nh c\u00f4ng ra m\u1eaft th\u01b0\u01a1ng m\u1ea1i SYMBRAVO)<\/li>\n<li><strong>Th\u00e1ng 7, 2025<\/strong>: 120-128 USD (s\u1ef1 ki\u1ec7n rung chu\u00f4ng NASDAQ + ng\u00e0y R&#038;D)<\/li>\n<li><strong>Th\u00e1ng 8, 2025<\/strong>: 105-112 USD (ch\u1ed1t l\u1eddi sau Q2 + bi\u1ebfn \u0111\u1ed9ng th\u1ecb tr\u01b0\u1eddng)<\/li>\n<\/ul>\n<p><strong>T\u1ea1i sao xu h\u01b0\u1edbng t\u0103ng chung?<\/strong><\/p>\n<ul>\n<li>T\u0103ng tr\u01b0\u1edfng doanh thu k\u1ef7 l\u1ee5c: 62% YoY trong Q1, 72% YoY trong Q2<\/li>\n<li>Ra m\u1eaft th\u00e0nh c\u00f4ng thu\u1ed1c \u0111i\u1ec1u tr\u1ecb \u0111au n\u1eeda \u0111\u1ea7u SYMBRAVO<\/li>\n<li>Nhi\u1ec1u ti\u1ebfn tri\u1ec3n trong c\u00e1c th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n 3<\/li>\n<li>M\u1edf r\u1ed9ng ti\u1ebfp c\u1eadn th\u1ecb tr\u01b0\u1eddng cho t\u1ea5t c\u1ea3 s\u1ea3n ph\u1ea9m<\/li>\n<\/ul>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/vt\/register\/\" class=\"po-cta-green\">B\u1eaft \u0111\u1ea7u giao d\u1ecbch\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2>\n<p>D\u1ef1a tr\u00ean s\u1ef1 \u0111\u1ed3ng thu\u1eadn c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch hi\u1ec7n t\u1ea1i v\u00e0 c\u00e1c ph\u00e1t tri\u1ec3n trong pipeline, \u0111\u00e2y l\u00e0 nh\u1eefng g\u00ec b\u1ea1n c\u00f3 th\u1ec3 mong \u0111\u1ee3i:<\/p>\n<ul>\n<li><strong>M\u1ee5c ti\u00eau cu\u1ed1i n\u0103m 2025<\/strong>: Ph\u1ea1m vi 140-160 USD (t\u0103ng 25-40% so v\u1edbi m\u1ee9c hi\u1ec7n t\u1ea1i)<br \/> C\u00e1c nh\u00e0 ph\u00e2n t\u00edch duy tr\u00ec \u0111\u00e1nh gi\u00e1 &#8220;Mua M\u1ea1nh&#8221; v\u1edbi m\u1ee5c ti\u00eau gi\u00e1 trung b\u00ecnh kho\u1ea3ng 176-178 USD, m\u1eb7c d\u00f9 c\u00e1c \u01b0\u1edbc t\u00ednh th\u1eadn tr\u1ecdng h\u01a1n cho r\u1eb1ng 140-150 USD l\u00e0 kh\u1ea3 thi trong \u0111i\u1ec1u ki\u1ec7n th\u1ecb tr\u01b0\u1eddng hi\u1ec7n t\u1ea1i.<\/li>\n<li><strong>D\u1ef1 b\u00e1o 2026<\/strong>: 180-220 USD<br \/> D\u1ef1 b\u00e1o n\u00e0y gi\u1ea3 \u0111\u1ecbnh c\u00e1c ph\u00ea duy\u1ec7t NDA th\u00e0nh c\u00f4ng cho AXS-05 trong \u0111i\u1ec1u tr\u1ecb k\u00edch \u0111\u1ed9ng Alzheimer v\u00e0 AXS-12 trong ch\u1ee9ng ng\u1ee7 r\u0169, c\u00f9ng v\u1edbi t\u0103ng tr\u01b0\u1edfng doanh thu ti\u1ebfp t\u1ee5c t\u1eeb c\u00e1c s\u1ea3n ph\u1ea9m hi\u1ec7n c\u00f3.<\/li>\n<li><strong>Tri\u1ec3n v\u1ecdng 2028<\/strong>: 250-350 USD<br \/> \u0110\u1ebfn n\u0103m 2028, d\u1ef1 ki\u1ebfn s\u1ebd c\u00f3 nhi\u1ec1u s\u1ea3n ph\u1ea9m m\u1edbi ra m\u1eaft v\u00e0 kh\u1ea3 n\u0103ng m\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng qu\u1ed1c t\u1ebf, th\u00fac \u0111\u1ea9y \u0111a d\u1ea1ng h\u00f3a doanh thu \u0111\u00e1ng k\u1ec3.<\/li>\n<li><strong>T\u1ea7m nh\u00ecn d\u00e0i h\u1ea1n 2030<\/strong>: 400-600 USD<br \/> N\u1ebfu Axsome th\u1ef1c hi\u1ec7n th\u00e0nh c\u00f4ng chi\u1ebfn l\u01b0\u1ee3c pipeline v\u00e0 chi\u1ebfm \u0111\u01b0\u1ee3c ngay c\u1ea3 m\u1ed9t ph\u1ea7n nh\u1ecf trong th\u1ecb tr\u01b0\u1eddng h\u01a1n 150 tri\u1ec7u b\u1ec7nh nh\u00e2n m\u00e0 h\u1ecd nh\u1eafm t\u1edbi, c\u1ed5 phi\u1ebfu c\u00f3 th\u1ec3 mang l\u1ea1i l\u1ee3i nhu\u1eadn d\u00e0i h\u1ea1n xu\u1ea5t s\u1eafc.<\/li>\n<\/ul>\n<p><strong>K\u1ebft lu\u1eadn<\/strong>: MUA M\u1ea0NH cho nh\u00e0 \u0111\u1ea7u t\u01b0 d\u00e0i h\u1ea1n. C\u00e1c nh\u00e0 giao d\u1ecbch ng\u1eafn h\u1ea1n n\u00ean ch\u1edd \u0111\u1ee3i kh\u1ea3 n\u0103ng gi\u1ea3m gi\u00e1 sau b\u00e1o c\u00e1o thu nh\u1eadp v\u00e0o th\u00e1ng 11.<\/p>\n<h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2>\n<h3>R\u1ee7i Ro C\u1ea7n Xem X\u00e9t<\/h3>\n<ul>\n<li><strong>Th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/strong>: D\u00f9 hi\u1ec7n t\u1ea1i th\u00e0nh c\u00f4ng, b\u1ea5t k\u1ef3 th\u1ea5t b\u1ea1i n\u00e0o trong th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n 3 c\u0169ng c\u00f3 th\u1ec3 khi\u1ebfn c\u1ed5 phi\u1ebfu gi\u1ea3m 30-50% ngay l\u1eadp t\u1ee9c. Ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ea5t bi\u1ebfn \u0111\u1ed9ng quanh k\u1ebft qu\u1ea3 l\u00e2m s\u00e0ng.<\/li>\n<li><strong>R\u00e0o c\u1ea3n quy \u0111\u1ecbnh FDA<\/strong>: Ngay c\u1ea3 khi th\u1eed nghi\u1ec7m th\u00e0nh c\u00f4ng, vi\u1ec7c FDA t\u1eeb ch\u1ed1i ho\u1eb7c tr\u00ec ho\u00e3n c\u00f3 th\u1ec3 l\u00e0m gi\u00e1 c\u1ed5 phi\u1ebfu s\u1ee5t gi\u1ea3m nghi\u00eam tr\u1ecdng. Vi\u1ec7c c\u00e1c quan ch\u1ee9c FDA ch\u1ee7 ch\u1ed1t g\u1ea7n \u0111\u00e2y r\u1eddi \u0111i l\u00e0m t\u0103ng s\u1ef1 kh\u00f4ng ch\u1eafc ch\u1eafn (<a href=\"https:\/\/www.pharmavoice.com\/news\/biotech-market-ipos-manda-stocks-pharma\/745288\/\">PharmaVoice<\/a>).<\/li>\n<li><strong>C\u1ea1nh tranh gia t\u0103ng<\/strong>: C\u00e1c c\u00f4ng ty d\u01b0\u1ee3c l\u1edbn h\u01a1n \u0111ang ph\u00e1t tri\u1ec3n c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb th\u1ea7n kinh h\u1ecdc c\u1ea1nh tranh c\u00f3 th\u1ec3 l\u00e0m gi\u1ea3m th\u1ecb ph\u1ea7n.<\/li>\n<li><strong>Kh\u1ea3 n\u0103ng t\u00e0i ch\u00ednh b\u1ec1n v\u1eefng<\/strong>: M\u1eb7c d\u00f9 doanh thu t\u0103ng \u1ea5n t\u01b0\u1ee3ng, c\u00f4ng ty v\u1eabn ho\u1ea1t \u0111\u1ed9ng thua l\u1ed7 (-246,9 tri\u1ec7u USD TTM). Thua l\u1ed7 ti\u1ebfp t\u1ee5c \u0111\u00f2i h\u1ecfi t\u00e0i tr\u1ee3 th\u00eam c\u00f3 th\u1ec3 l\u00e0m pha lo\u00e3ng gi\u00e1 tr\u1ecb c\u1ed5 \u0111\u00f4ng.<\/li>\n<\/ul>\n<h3>T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c Cho 2025-2026<\/h3>\n<ul>\n<li><strong>T\u0103ng tr\u01b0\u1edfng doanh thu b\u00f9ng n\u1ed5<\/strong>: T\u0103ng tr\u01b0\u1edfng 72% theo n\u0103m trong Q2 2025 cho th\u1ea5y th\u1ef1c thi th\u01b0\u01a1ng m\u1ea1i m\u1ea1nh m\u1ebd (<a href=\"https:\/\/www.biospace.com\/press-releases\/axsome-therapeutics-reports-second-quarter-2025-financial-results-and-provides-business-update\">BioSpace<\/a>).<\/li>\n<li><strong>\u0110\u00e0 ph\u00e1t tri\u1ec3n pipeline<\/strong>: B\u1ed1n th\u1eed nghi\u1ec7m Giai \u0111o\u1ea1n 3 b\u1ed5 sung b\u1eaft \u0111\u1ea7u trong Q4 2025 tr\u00ean c\u00e1c ch\u1ec9 \u0111\u1ecbnh l\u1edbn bao g\u1ed3m cai thu\u1ed1c l\u00e1 v\u00e0 ADHD tr\u1ebb em.<\/li>\n<li><strong>M\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng<\/strong>: Vi\u1ec7c ra m\u1eaft th\u01b0\u01a1ng m\u1ea1i SYMBRAVO v\u00e0o th\u00e1ng 6 n\u0103m 2025 b\u1ed5 sung d\u00f2ng doanh thu m\u1edbi b\u00ean c\u1ea1nh th\u00e0nh c\u00f4ng c\u1ee7a AUVELITY.<\/li>\n<li><strong>Xu h\u01b0\u1edbng ng\u00e0nh<\/strong>: C\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb th\u1ea7n kinh h\u1ecdc l\u00e0 m\u1ed9t trong nh\u1eefng l\u0129nh v\u1ef1c d\u01b0\u1ee3c ph\u1ea9m ph\u00e1t tri\u1ec3n nhanh nh\u1ea5t, v\u1edbi s\u1ef1 gia t\u0103ng b\u1ea3o hi\u1ec3m v\u00e0 nhu c\u1ea7u b\u1ec7nh nh\u00e2n.<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2>\n<p><strong>\u0110i\u1ec3m v\u00e0o chi\u1ebfn l\u01b0\u1ee3c<\/strong>:<\/p>\n<ol>\n<li>S\u1eed d\u1ee5ng ph\u01b0\u01a1ng ph\u00e1p trung b\u00ecnh gi\u00e1 theo \u0111\u00f4 la\u2014\u0111\u1ea7u t\u01b0 s\u1ed1 ti\u1ec1n c\u1ed1 \u0111\u1ecbnh h\u00e0ng tu\u1ea7n thay v\u00ec c\u1ed1 g\u1eafng b\u1eaft th\u1eddi \u0111i\u1ec3m th\u1ecb tr\u01b0\u1eddng<\/li>\n<li>\u0110\u1eb7t l\u1ec7nh mua \u1edf m\u1ee9c 105-108 USD \u0111\u1ec3 c\u00f3 gi\u00e1 v\u00e0o t\u1ed1t h\u01a1n<\/li>\n<li>Ph\u00e2n b\u1ed5 kh\u00f4ng qu\u00e1 5-10% danh m\u1ee5c cho c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc c\u00f3 bi\u1ebfn \u0111\u1ed9ng cao<\/li>\n<\/ol>\n<p><strong>Qu\u1ea3n l\u00fd r\u1ee7i ro thi\u1ebft y\u1ebfu<\/strong>:<\/p>\n<ul>\n<li>\u0110\u1eb7t l\u1ec7nh d\u1eebng l\u1ed7 \u1edf m\u1ee9c 15-20% d\u01b0\u1edbi \u0111i\u1ec3m v\u00e0o<\/li>\n<li>Ch\u1ed1t l\u1eddi m\u1ed9t ph\u1ea7n khi l\u1ee3i nhu\u1eadn \u0111\u1ea1t 25-30% \u0111\u1ec3 b\u1ea3o v\u1ec7 l\u1ee3i nhu\u1eadn<\/li>\n<li>Theo d\u00f5i l\u1ecbch FDA cho c\u00e1c ng\u00e0y quy\u1ebft \u0111\u1ecbnh s\u1eafp t\u1edbi<\/li>\n<\/ul>\n<p><strong>Ch\u00e2m ng\u00f4n h\u00e0i h\u01b0\u1edbc cho nh\u00e0 giao d\u1ecbch<\/strong>: &#8220;Giao d\u1ecbch c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 v\u1edbi m\u1ed9t nh\u00e0 khoa h\u1ecdc t\u00e0i ba\u2014\u0111\u1ed9t ph\u00e1 h\u1ed3i h\u1ed9p pha l\u1eabn nh\u1eefng v\u1ee5 n\u1ed5 ph\u00f2ng th\u00ed nghi\u1ec7m th\u1ec9nh tho\u1ea3ng. Lu\u00f4n \u0111eo k\u00ednh b\u1ea3o h\u1ed9 an to\u00e0n!&#8221;<\/p>\n<h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Axsome Therapeutics, Inc. (AXSM) &#8211; T\u1eebng B\u01b0\u1edbc<\/h2>\n<table>\n<thead>\n<tr>\n<th>B\u01b0\u1edbc<\/th>\n<th>H\u00e0nh \u0110\u1ed9ng<\/th>\n<th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch c\u1ed5 phi\u1ebfu<\/td>\n<td>\u0110\u1ea3m b\u1ea3o n\u1ec1n t\u1ea3ng c\u00f3 truy c\u1eadp NASDAQ v\u00e0 cho ph\u00e9p mua c\u1ed5 phi\u1ebfu l\u1ebb<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>M\u1edf v\u00e0 n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n<\/td>\n<td>B\u1eaft \u0111\u1ea7u v\u1edbi 50-100 USD \u0111\u1ec3 l\u00e0m quen v\u1edbi c\u01a1 ch\u1ebf n\u1ec1n t\u1ea3ng<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Nghi\u00ean c\u1ee9u c\u00e1c y\u1ebfu t\u1ed1 c\u01a1 b\u1ea3n c\u1ee7a AXSM<\/td>\n<td>Xem x\u00e9t t\u0103ng tr\u01b0\u1edfng doanh thu, tr\u1ea1ng th\u00e1i pipeline v\u00e0 \u0111\u00e1nh gi\u00e1 c\u1ee7a nh\u00e0 ph\u00e2n t\u00edch<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1<\/td>\n<td>Nh\u1eadn th\u00f4ng b\u00e1o t\u1ea1i c\u00e1c m\u1ee9c h\u1ed7 tr\u1ee3 ch\u00ednh (105 USD, 100 USD, 95 USD)<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Th\u1ef1c hi\u1ec7n l\u1ec7nh gi\u1edbi h\u1ea1n<\/td>\n<td>Mua \u1edf gi\u00e1 m\u1ee5c ti\u00eau thay v\u00ec gi\u00e1 th\u1ecb tr\u01b0\u1eddng<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Theo d\u00f5i v\u1ecb th\u1ebf th\u01b0\u1eddng xuy\u00ean<\/td>\n<td>Theo d\u00f5i ng\u00e0y c\u00f4ng b\u1ed1 thu nh\u1eadp v\u00e0 c\u00e1c m\u1ed1c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>\u00c1p d\u1ee5ng qu\u1ea3n l\u00fd r\u1ee7i ro<\/td>\n<td>\u0110\u1eb7t m\u1ee9c d\u1eebng l\u1ed7 v\u00e0 ch\u1ed1t l\u1eddi ngay l\u1eadp t\u1ee9c<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Xem x\u00e9t b\u00e1o c\u00e1o h\u00e0ng qu\u00fd<\/td>\n<td>C\u1eadp nh\u1eadt v\u1ec1 t\u0103ng tr\u01b0\u1edfng doanh thu v\u00e0 ti\u1ebfn tri\u1ec3n pipeline<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Xem x\u00e9t t\u00e1i \u0111\u1ea7u t\u01b0 c\u1ed5 t\u1ee9c<\/td>\n<td>N\u1ebfu c\u00f3, t\u1ef1 \u0111\u1ed9ng t\u00e1i \u0111\u1ea7u t\u01b0 l\u1ee3i nhu\u1eadn<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>\u0110i\u1ec1u ch\u1ec9nh c\u00e2n b\u1eb1ng \u0111\u1ecbnh k\u1ef3<\/td>\n<td>\u0110i\u1ec1u ch\u1ec9nh k\u00edch th\u01b0\u1edbc v\u1ecb th\u1ebf khi gi\u00e1 tr\u1ecb danh m\u1ee5c thay \u0111\u1ed5i<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 AXSM M\u1edbi<\/h2>\n<p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi mu\u1ed1n b\u1eaft \u0111\u1ea7u v\u1edbi Axsome Therapeutics, Pocket Option cung c\u1ea5p kh\u1ea3 n\u0103ng ti\u1ebfp c\u1eadn xu\u1ea5t s\u1eafc:<\/p>\n<ul>\n<li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u ch\u1ec9 5 USD<\/strong>\u2014th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi r\u1ee7i ro t\u1ed1i thi\u1ec3u tr\u01b0\u1edbc khi cam k\u1ebft s\u1ed1 ti\u1ec1n l\u1edbn h\u01a1n<\/li>\n<li><strong>X\u00e1c minh KYC trong 1 ph\u00fat<\/strong>\u2014b\u1eaft \u0111\u1ea7u giao d\u1ecbch nhanh ch\u00f3ng v\u1edbi b\u1ea5t k\u1ef3 gi\u1ea5y t\u1edd t\u00f9y th\u00e2n ch\u00ednh ph\u1ee7 n\u00e0o<\/li>\n<li><strong>H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong>\u2014linh ho\u1ea1t v\u1edbi ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed v\u00e0 c\u00e1c ph\u01b0\u01a1ng th\u1ee9c truy\u1ec1n th\u1ed1ng<\/li>\n<li><strong>Truy c\u1eadp c\u1ed5 phi\u1ebfu l\u1ebb<\/strong>\u2014mua ph\u1ea7n nh\u1ecf c\u1ee7a AXSM ngay c\u1ea3 v\u1edbi t\u00e0i kho\u1ea3n nh\u1ecf<\/li>\n<li><strong>D\u1eef li\u1ec7u th\u1ecb tr\u01b0\u1eddng th\u1eddi gian th\u1ef1c<\/strong>\u2014theo d\u00f5i bi\u1ebfn \u0111\u1ed9ng gi\u00e1 AXSM v\u00e0 \u0111\u1eb7t c\u1ea3nh b\u00e1o ngay l\u1eadp t\u1ee9c<\/li>\n<\/ul>\n<p>Giao di\u1ec7n th\u00e2n thi\u1ec7n v\u1edbi ng\u01b0\u1eddi d\u00f9ng c\u1ee7a n\u1ec1n t\u1ea3ng l\u00e0m cho n\u00f3 l\u00fd t\u01b0\u1edfng cho ng\u01b0\u1eddi m\u1edbi mu\u1ed1n tham gia \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc m\u00e0 kh\u00f4ng ph\u1ea3i \u0111\u1ed1i m\u1eb7t v\u1edbi s\u1ef1 ph\u1ee9c t\u1ea1p c\u1ee7a c\u00e1c t\u00e0i kho\u1ea3n m\u00f4i gi\u1edbi truy\u1ec1n th\u1ed1ng.<\/p>\n<h2>\ud83c\udf0d Axsome Therapeutics N\u0103m 2025: Nh\u00e0 L\u00e3nh \u0110\u1ea1o \u0110\u1ed5i M\u1edbi Th\u1ea7n Kinh H\u1ecdc<\/h2>\n<p>Axsome Therapeutics \u0111\u1ee9ng \u1edf v\u1ecb tr\u00ed ti\u00ean phong trong \u0111\u1ed5i m\u1edbi \u0111i\u1ec1u tr\u1ecb h\u1ec7 th\u1ea7n kinh trung \u01b0\u01a1ng. C\u00f4ng ty hi\u1ec7n \u0111ang ti\u1ebfp th\u1ecb hai s\u1ea3n ph\u1ea9m th\u00e0nh c\u00f4ng\u2014AUVELITY cho tr\u1ea7m c\u1ea3m v\u00e0 SUNOSI cho r\u1ed1i lo\u1ea1n gi\u1ea5c ng\u1ee7\u2014v\u1edbi SYMBRAVO v\u1eeba \u0111\u01b0\u1ee3c ra m\u1eaft cho \u0111i\u1ec1u tr\u1ecb \u0111au n\u1eeda \u0111\u1ea7u c\u1ea5p t\u00ednh.<\/p>\n<p>Pipeline c\u1ee7a c\u00f4ng ty l\u00e0 m\u1ed9t trong nh\u1eefng m\u1ea1nh m\u1ebd nh\u1ea5t trong l\u0129nh v\u1ef1c th\u1ea7n kinh h\u1ecdc, v\u1edbi c\u00e1c NDA \u0111\u00e3 n\u1ed9p cho b\u1ec7nh \u0111au c\u01a1 x\u01a1 h\u00f3a (AXS-14) v\u00e0 k\u1ebf ho\u1ea1ch n\u1ed9p cho k\u00edch \u0111\u1ed9ng Alzheimer (AXS-05) v\u00e0 ch\u1ee9ng ng\u1ee7 r\u0169 (AXS-12). Chi\u1ebfn l\u01b0\u1ee3c R&#038;D c\u1ee7a h\u1ecd nh\u1eafm \u0111\u1ebfn c\u00e1c b\u1ec7nh \u1ea3nh h\u01b0\u1edfng h\u01a1n 150 tri\u1ec7u b\u1ec7nh nh\u00e2n ch\u1ec9 ri\u00eang t\u1ea1i M\u1ef9, \u0111\u1ea1i di\u1ec7n cho ti\u1ec1m n\u0103ng th\u1ecb tr\u01b0\u1eddng kh\u1ed5ng l\u1ed3.<\/p>\n<p><strong>S\u1ef1 ki\u1ec7n th\u00fa v\u1ecb n\u0103m 2025<\/strong>: Axsome \u0111\u00e3 g\u00e2y ch\u00fa \u00fd khi rung chu\u00f4ng khai m\u1ea1c NASDAQ v\u00e0o ng\u00e0y 21 th\u00e1ng 7\u2014nh\u01b0ng v\u1edbi m\u1ed9t \u0111i\u1ec3m \u0111\u1eb7c bi\u1ec7t. H\u1ecd s\u1eed d\u1ee5ng c\u00f4ng ngh\u1ec7 \u0111\u1ecdc s\u00f3ng n\u00e3o cho ph\u00e9p CEO Herriot Tabuteau k\u00edch ho\u1ea1t chu\u00f4ng ch\u1ec9 b\u1eb1ng suy ngh\u0129 t\u1eadp trung, th\u1ec3 hi\u1ec7n cam k\u1ebft \u0111\u1ed5i m\u1edbi th\u1ea7n kinh h\u1ecdc v\u01b0\u1ee3t ra ngo\u00e0i d\u01b0\u1ee3c ph\u1ea9m.<\/p>\n"},"faq":[{"question":"Axsome Therapeutics l\u00e0 c\u00f4ng ty g\u00ec?","answer":"Axsome Therapeutics l\u00e0 m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc chuy\u00ean ph\u00e1t tri\u1ec3n c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb \u0111\u1ed9t ph\u00e1 cho c\u00e1c b\u1ec7nh th\u1ea7n kinh nh\u01b0 tr\u1ea7m c\u1ea3m, \u0111au n\u1eeda \u0111\u1ea7u v\u00e0 r\u1ed1i lo\u1ea1n gi\u1ea5c ng\u1ee7."},{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu AXSM?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu AXSM th\u00f4ng qua c\u00e1c n\u1ec1n t\u1ea3ng giao d\u1ecbch ch\u1ee9ng kho\u00e1n c\u00f3 h\u1ed7 tr\u1ee3 NASDAQ, s\u1eed d\u1ee5ng c\u00e1c l\u1ec7nh gi\u1edbi h\u1ea1n v\u00e0 theo d\u00f5i c\u00e1c \u0111i\u1ec3m v\u00e0o chi\u1ebfn l\u01b0\u1ee3c \u0111\u01b0\u1ee3c \u0111\u1ec1 xu\u1ea5t."},{"question":"R\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o AXSM l\u00e0 g\u00ec?","answer":"R\u1ee7i ro bao g\u1ed3m th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, c\u00e1c r\u00e0o c\u1ea3n quy \u0111\u1ecbnh t\u1eeb FDA, c\u1ea1nh tranh gia t\u0103ng v\u00e0 kh\u1ea3 n\u0103ng t\u00e0i ch\u00ednh ch\u01b0a b\u1ec1n v\u1eefng do c\u00f4ng ty v\u1eabn \u0111ang thua l\u1ed7."},{"question":"D\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu AXSM trong t\u01b0\u01a1ng lai nh\u01b0 th\u1ebf n\u00e0o?","answer":"D\u1ef1 b\u00e1o cho th\u1ea5y gi\u00e1 c\u1ed5 phi\u1ebfu c\u00f3 th\u1ec3 t\u0103ng l\u00ean 140-160 USD v\u00e0o cu\u1ed1i n\u0103m 2025, ti\u1ebfp t\u1ee5c t\u0103ng l\u00ean 180-220 USD n\u0103m 2026, v\u00e0 c\u00f3 th\u1ec3 \u0111\u1ea1t 400-600 USD v\u00e0o n\u0103m 2030 n\u1ebfu c\u00f4ng ty th\u1ef1c hi\u1ec7n th\u00e0nh c\u00f4ng chi\u1ebfn l\u01b0\u1ee3c c\u1ee7a m\u00ecnh."},{"question":"Pocket Option c\u00f3 ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi kh\u00f4ng?","answer":"C\u00f3, Pocket Option r\u1ea5t ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi nh\u1edd s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, x\u00e1c minh nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n, truy c\u1eadp c\u1ed5 phi\u1ebfu l\u1ebb v\u00e0 giao di\u1ec7n th\u00e2n thi\u1ec7n v\u1edbi ng\u01b0\u1eddi d\u00f9ng."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Axsome Therapeutics l\u00e0 c\u00f4ng ty g\u00ec?","answer":"Axsome Therapeutics l\u00e0 m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc chuy\u00ean ph\u00e1t tri\u1ec3n c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb \u0111\u1ed9t ph\u00e1 cho c\u00e1c b\u1ec7nh th\u1ea7n kinh nh\u01b0 tr\u1ea7m c\u1ea3m, \u0111au n\u1eeda \u0111\u1ea7u v\u00e0 r\u1ed1i lo\u1ea1n gi\u1ea5c ng\u1ee7."},{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu AXSM?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu AXSM th\u00f4ng qua c\u00e1c n\u1ec1n t\u1ea3ng giao d\u1ecbch ch\u1ee9ng kho\u00e1n c\u00f3 h\u1ed7 tr\u1ee3 NASDAQ, s\u1eed d\u1ee5ng c\u00e1c l\u1ec7nh gi\u1edbi h\u1ea1n v\u00e0 theo d\u00f5i c\u00e1c \u0111i\u1ec3m v\u00e0o chi\u1ebfn l\u01b0\u1ee3c \u0111\u01b0\u1ee3c \u0111\u1ec1 xu\u1ea5t."},{"question":"R\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o AXSM l\u00e0 g\u00ec?","answer":"R\u1ee7i ro bao g\u1ed3m th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, c\u00e1c r\u00e0o c\u1ea3n quy \u0111\u1ecbnh t\u1eeb FDA, c\u1ea1nh tranh gia t\u0103ng v\u00e0 kh\u1ea3 n\u0103ng t\u00e0i ch\u00ednh ch\u01b0a b\u1ec1n v\u1eefng do c\u00f4ng ty v\u1eabn \u0111ang thua l\u1ed7."},{"question":"D\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu AXSM trong t\u01b0\u01a1ng lai nh\u01b0 th\u1ebf n\u00e0o?","answer":"D\u1ef1 b\u00e1o cho th\u1ea5y gi\u00e1 c\u1ed5 phi\u1ebfu c\u00f3 th\u1ec3 t\u0103ng l\u00ean 140-160 USD v\u00e0o cu\u1ed1i n\u0103m 2025, ti\u1ebfp t\u1ee5c t\u0103ng l\u00ean 180-220 USD n\u0103m 2026, v\u00e0 c\u00f3 th\u1ec3 \u0111\u1ea1t 400-600 USD v\u00e0o n\u0103m 2030 n\u1ebfu c\u00f4ng ty th\u1ef1c hi\u1ec7n th\u00e0nh c\u00f4ng chi\u1ebfn l\u01b0\u1ee3c c\u1ee7a m\u00ecnh."},{"question":"Pocket Option c\u00f3 ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi kh\u00f4ng?","answer":"C\u00f3, Pocket Option r\u1ea5t ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi nh\u1edd s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, x\u00e1c minh nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n, truy c\u1eadp c\u1ed5 phi\u1ebfu l\u1ebb v\u00e0 giao di\u1ec7n th\u00e2n thi\u1ec7n v\u1edbi ng\u01b0\u1eddi d\u00f9ng."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e1ch mua c\u1ed5 phi\u1ebfu Axsome Therapeutics, Inc. (AXSM) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Axsome Therapeutics, Inc. (AXSM)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Axsome Therapeutics, Inc. (AXSM) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Axsome Therapeutics, Inc. (AXSM)\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-20T17:25:54+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Axsome Therapeutics, Inc. (AXSM) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Axsome Therapeutics, Inc. (AXSM)\",\"datePublished\":\"2025-08-20T17:25:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/\"},\"wordCount\":23,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/\",\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Axsome Therapeutics, Inc. (AXSM) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Axsome Therapeutics, Inc. (AXSM)\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"datePublished\":\"2025-08-20T17:25:54+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Axsome Therapeutics, Inc. (AXSM) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Axsome Therapeutics, Inc. (AXSM)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Axsome Therapeutics, Inc. (AXSM) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Axsome Therapeutics, Inc. (AXSM)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/","og_locale":"en_US","og_type":"article","og_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Axsome Therapeutics, Inc. (AXSM) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Axsome Therapeutics, Inc. (AXSM)","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-20T17:25:54+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Axsome Therapeutics, Inc. (AXSM) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Axsome Therapeutics, Inc. (AXSM)","datePublished":"2025-08-20T17:25:54+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/"},"wordCount":23,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/","url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/","name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Axsome Therapeutics, Inc. (AXSM) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Axsome Therapeutics, Inc. (AXSM)","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","datePublished":"2025-08-20T17:25:54+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Axsome Therapeutics, Inc. (AXSM) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Axsome Therapeutics, Inc. (AXSM)"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":342260,"slug":"how-to-buy-axsome-therapeutics","post_title":"Como comprar a\u00e7\u00f5es da Axsome Therapeutics, Inc. (AXSM) - Investimento em a\u00e7\u00f5es da Axsome Therapeutics, Inc. (AXSM)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-axsome-therapeutics\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/342267","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=342267"}],"version-history":[{"count":1,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/342267\/revisions"}],"predecessor-version":[{"id":342269,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/342267\/revisions\/342269"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/334054"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=342267"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=342267"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=342267"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}